Cargando…
Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study
OBJECTIVES: To prevent pain inhibiting their performance, many athletes ingest over-the-counter (OTC) analgesics before competing. We aimed at defining the use of analgesics and the relation between OTC analgesic use/dose and adverse events (AEs) during and after the race, a relation that has not be...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641448/ https://www.ncbi.nlm.nih.gov/pubmed/23604350 http://dx.doi.org/10.1136/bmjopen-2012-002090 |
_version_ | 1782268025170296832 |
---|---|
author | Küster, Michael Renner, Bertold Oppel, Pascal Niederweis, Ursula Brune, Kay |
author_facet | Küster, Michael Renner, Bertold Oppel, Pascal Niederweis, Ursula Brune, Kay |
author_sort | Küster, Michael |
collection | PubMed |
description | OBJECTIVES: To prevent pain inhibiting their performance, many athletes ingest over-the-counter (OTC) analgesics before competing. We aimed at defining the use of analgesics and the relation between OTC analgesic use/dose and adverse events (AEs) during and after the race, a relation that has not been investigated to date. DESIGN: Prospective (non-interventional) cohort study, using an online questionnaire. SETTING: The Bonn marathon 2010. PARTICIPANTS: 3913 of 7048 participants in the Bonn marathon 2010 returned their questionnaires. PRIMARY AND SECONDARY OUTCOMES: Intensity of analgesic consumption before sports; incidence of AEs in the cohort of analgesic users as compared to non-users. RESULTS: There was no significant difference between the premature race withdrawal rate in the analgesics cohort and the cohort who did not take analgesics (‘controls’). However, race withdrawal because of gastrointestinal AEs was significantly more frequent in the analgesics cohort than in the control. Conversely, withdrawal because of muscle cramps was rare, but it was significantly more frequent in controls. The analgesics cohort had an almost 5 times higher incidence of AEs (overall risk difference of 13%). This incidence increased significantly with increasing analgesic dose. Nine respondents reported temporary hospital admittance: three for temporary kidney failure (post-ibuprofen ingestion), four with bleeds (post-aspirin ingestion) and two cardiac infarctions (post-aspirin ingestion). None of the control reported hospital admittance. CONCLUSIONS: The use of analgesics before participating in endurance sports may cause many potentially serious, unwanted AEs that increase with increasing analgesic dose. Analgesic use before endurance sports appears to pose an unrecognised medical problem as yet. If verifiable in other endurance sports, it requires the attention of physicians and regulatory authorities. |
format | Online Article Text |
id | pubmed-3641448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-36414482013-05-07 Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study Küster, Michael Renner, Bertold Oppel, Pascal Niederweis, Ursula Brune, Kay BMJ Open Sports and Exercise Medicine OBJECTIVES: To prevent pain inhibiting their performance, many athletes ingest over-the-counter (OTC) analgesics before competing. We aimed at defining the use of analgesics and the relation between OTC analgesic use/dose and adverse events (AEs) during and after the race, a relation that has not been investigated to date. DESIGN: Prospective (non-interventional) cohort study, using an online questionnaire. SETTING: The Bonn marathon 2010. PARTICIPANTS: 3913 of 7048 participants in the Bonn marathon 2010 returned their questionnaires. PRIMARY AND SECONDARY OUTCOMES: Intensity of analgesic consumption before sports; incidence of AEs in the cohort of analgesic users as compared to non-users. RESULTS: There was no significant difference between the premature race withdrawal rate in the analgesics cohort and the cohort who did not take analgesics (‘controls’). However, race withdrawal because of gastrointestinal AEs was significantly more frequent in the analgesics cohort than in the control. Conversely, withdrawal because of muscle cramps was rare, but it was significantly more frequent in controls. The analgesics cohort had an almost 5 times higher incidence of AEs (overall risk difference of 13%). This incidence increased significantly with increasing analgesic dose. Nine respondents reported temporary hospital admittance: three for temporary kidney failure (post-ibuprofen ingestion), four with bleeds (post-aspirin ingestion) and two cardiac infarctions (post-aspirin ingestion). None of the control reported hospital admittance. CONCLUSIONS: The use of analgesics before participating in endurance sports may cause many potentially serious, unwanted AEs that increase with increasing analgesic dose. Analgesic use before endurance sports appears to pose an unrecognised medical problem as yet. If verifiable in other endurance sports, it requires the attention of physicians and regulatory authorities. BMJ Publishing Group 2013-04-19 /pmc/articles/PMC3641448/ /pubmed/23604350 http://dx.doi.org/10.1136/bmjopen-2012-002090 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
spellingShingle | Sports and Exercise Medicine Küster, Michael Renner, Bertold Oppel, Pascal Niederweis, Ursula Brune, Kay Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study |
title | Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study |
title_full | Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study |
title_fullStr | Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study |
title_full_unstemmed | Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study |
title_short | Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study |
title_sort | consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study |
topic | Sports and Exercise Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641448/ https://www.ncbi.nlm.nih.gov/pubmed/23604350 http://dx.doi.org/10.1136/bmjopen-2012-002090 |
work_keys_str_mv | AT kustermichael consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy AT rennerbertold consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy AT oppelpascal consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy AT niederweisursula consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy AT brunekay consumptionofanalgesicsbeforeamarathonandtheincidenceofcardiovasculargastrointestinalandrenalproblemsacohortstudy |